Literature DB >> 437226

Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study.

F Reymann.   

Abstract

During the period 1966-1968, 88 patients with a total of 95 basal cell carcinomas were treated with 5% 5-fluorouracil ointment. A follow-up study carried out from November 1977 to January 1978 revealed a total of 12 recurrences in 56 surviving patients with 56 basal cell carcinomas. The recurrence rate is thus 21.4%. It is concluded that there is hardly any indication for using 5-fluorouracil in local treatment of nodular basal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437226     DOI: 10.1159/000250782

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  7 in total

1.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

Review 2.  [Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma].

Authors:  R-M Szeimies; S Karrer; H Bäcker
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

Review 3.  Diagnosis and Management of Basal Cell Carcinoma.

Authors:  Keiji Tanese
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

Review 4.  Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies.

Authors:  Julien Lanoue; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-05-01

5.  Total body topical 5-fluorouracil for extensive non-melanoma skin cancer.

Authors:  Serge van Ruth; Frank G A Jansman; Cornelis J Sanders
Journal:  Pharm World Sci       Date:  2006-09-27

Review 6.  Pharmacological treatments for basal cell carcinoma.

Authors:  Seongmu Lee; Dinesh Selva; Shyamala C Huilgol; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  Novel medical strategies combating nonmelanoma skin cancer.

Authors:  Prasan R Bhandari; Varadraj V Pai
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.